ShareLab

🌟 Exciting news from Cellmover 🌟 We are thrilled to announce that Cellmover has been awarded funding from the prestigious #Eurostars program in collaboration with our partner, RED GLEAD DISCOVERY, in Sweden. This support propels us forward as we advance our lead candidate, CM101—a nanobody-based therapy designed to fight lung cancer. It also reinforces our mission to innovate and develop novel biologics that can transform patient care. With this milestone, we are ready to elevate our research and make significant progress during the next years. The future of immunotherapy is bright, and we are excited to contribute to this transformative journey. Norges forskningsråd ShareLab The Life Science Cluster MedWatch Norge Innovasjon Norge forskning.no Forskningsparken - Oslo Science Park

We’re thrilled to officially welcome Geir Utigard as the newest member of the Regenics AS team! 🎉 Geir joined us back in October as Head of CMC and hit the ground running, diving straight into urgent and important tasks alongside the rest of the team. While we’re a bit late in celebrating his arrival, it’s never too late to highlight how much we appreciate having him on board. With his extensive expertise in product development also within the field of wound healing, Geir has already made a significant impact. We’re excited about the journey ahead and look forward to achieving great things together. Welcome to the team, Geir! 👏

🎉 Exciting milestone achieved! We’ve successfully completed the first round of aseptic manufacturing of our Collex® wound dressing under GMP standards—a huge step forward for Regenics AS! 🙌 100 units of Collex® are now ready to take another exciting step toward transforming how wounds are treated. A huge shoutout to Alv B AS, Francesca Gatti, Dr Nanda Tarte, Flore Kersten, and Geir Utigard for your expertise, dedication, and incredible teamwork. This achievement wouldn’t have been possible without your support, especially during the long hours in their manufacturing facility. It’s truly inspiring to collaborate with such amazing professionals. You rock! 🌟 Here’s to more milestones ahead! 🚀

🥇 The Vaccibody Innovation Award 2024 has been awarded to Esmaeil Dorraji ! 🏆 The award was created in 2020, when the founder of Vaccibody (now Nykode), Agnete Fredriksen, won the Research Council of Norway's Innovation Award. ✨ Graduating SPARKees are invited to pitch for this award at the SPARK Norway graduation session. This is the fourth time this has been awarded. 📎 More about the award and the graduating teams can be found here: https://lnkd.in/dU3vKweU 📸 Photo by Jarli&Jordan

🚀 Exciting News from Enzyferm! 🍻 In a few weeks we will launch our new range of dry multi-strain kveik yeast products, designed specifically for brewers and distillers. These innovative strains bring a fresh edge to fermentation, offering unique advantages over traditional brewer's yeast. 🔬 Why multi-strain Kveik? 1️⃣ Fast and Sustainable Fermentation: Kveik yeast is renowned for its high-temperature tolerance, allowing quicker fermentation without compromising flavor. It offers sustainability advantages by reducing energy consumption due to its ability to ferment efficiently at higher temperatures, reducing the need for extensive temperature control and cooling. 2️⃣ Distinct Flavor Profiles: Our multi-strain kveik yeast creates complex and nuanced flavors, providing brewers and distillers with a versatile toolkit to craft unique beverages. 3️⃣ Versatile fermentation: Our yeast is a nod to centuries-old Norwegian tradition, now optimized for modern brewing and distilling. Whether you're a craft brewer looking to experiment or a distiller searching for that signature note, our kveik yeast opens up endless possibilities. #KveikYeast #BrewingInnovation #CraftBeer #Distilling #FermentationScience #Yeast #BrewingBeer #KveikYeastery